A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Tolerability of Milnacipran 100mg/day in the Management of Fibromyalgia

被引：0
|
作者：
Arnold, Lesley [1 ]
Gendreau, R. Michael [1 ]
Spera, Allan [1 ]
Gendreau, Judy [1 ]
Wang, Yong [1 ]
机构：
[1] Univ Cincinnati, Cincinnati, OH 45221 USA
来源：
JOURNAL OF WOMENS HEALTH | 2010年 / 19卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
06
引用
收藏
页码：605 / 605
页数：1
相关论文
共 50 条
  • [1] The Efficacy and Tolerability of Milnacipran 100 mg/day Monotherapy for the Management of Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial
    Arnold, Lesley M.
    Gendreau, R. Michael
    Spera, Allan
    Gendreau, Judy
    Wang, Yong
    NEUROLOGY, 2010, 74 (09) : A187 - A187
  • [2] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SWITCH STUDY OF THE SAFETY, TOLERABILITY, AND EFFICACY OF MILNACIPRAN IN FIBROMYALGIA PATIENTS WHO INADEQUATELY RESPOND TO DULOXETINE
    Spera, Allan
    Bateman, Lucinda
    Palmer, Robert H.
    Trugman, Joel M.
    Lin, Jennifer
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2012, 27 : S103 - S104
  • [3] Milnacipran for the treatment of fibromyalgia syndrome: A randomized, double-blind, placebo-controlled trial
    Clauw, Daniel J.
    Palmer, Robert H.
    Thacker, Kim
    Gendreau, R. Michael
    Mease, Philip
    NEUROLOGY, 2008, 70 (11) : A162 - A162
  • [4] A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia
    Vitton, O
    Gendreau, M
    Gendreau, J
    Kranzler, J
    Rao, SG
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2004, 19 : S27 - S35
  • [5] Effect of Milnacipran on Pain in Fibromyalgia: A European, Double-Blind, Randomized, Placebo-Controlled Trial
    Branco, Jaime C.
    Danneskiold-Samsoe, Bent
    Cherin, Patrick
    Cantagrel, N.
    Vitton, Olivier
    Bunouf, Pierre
    Mainguy, Yves
    ANNALS OF NEUROLOGY, 2009, 66 : S4 - S5
  • [6] A Multicenter, Randomized, Double-Blind, Placebo-Controlled Switch Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Patients with An Inadequate Response to Duloxetine for the Treatment of Fibromyalgia
    Bateman, Lucinda
    Spera, Allan
    Palmer, Robert H.
    Trugman, Joel M.
    Lin, Jennifer
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S628 - S628
  • [7] Milnacipran efficacy in the treatment of fibromyalgia syndrome: A 15-week, randomized, double-blind, placebo-controlled trial
    Clauw, Daniel J.
    Palmer, Robert H.
    Thacker, Kim
    Gendreau, R. Michael
    Mease, Philip
    ARTHRITIS AND RHEUMATISM, 2007, 56 (12): : 4231 - 4231
  • [8] Effect of Milnacipran Treatment on Ventricular Lactate in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial
    Natelson, Benjamin H.
    Vu, Diana
    Mao, Xiangling
    Weiduschat, Nora
    Togo, Fumiharu
    Lange, Gudrun
    Blate, Michelle
    Kang, Guoxin
    Coplan, Jeremy D.
    Shungu, Dikoma C.
    JOURNAL OF PAIN, 2015, 16 (11): : 1211 - 1219
  • [9] AN ANALYSIS OF TWO RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS ASSESSING THE EFFECT OF MILNACIPRAN FOR FIBROMYALGIA
    Geisser, M. E.
    Palmer, R. H.
    Wang, Y.
    Gendreau, R. M.
    Trifilo, M.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 : 19 - 19
  • [10] Efficacy and Safety of Duloxetine 30 mg/d in Patients With Fibromyalgia A Randomized, Double-blind, Placebo-controlled Study
    Arnold, Lesley M.
    Zhang, Shuyu
    Pangallo, Beth A.
    CLINICAL JOURNAL OF PAIN, 2012, 28 (09): : 775 - 781
12345